Navigation Links
Dilon Diagnostics Receives ISO 13485 Certification
Date:3/2/2010

NEWPORT NEWS, Va., March 2 /PRNewswire/ -- Dilon Diagnostics, a manufacturer and supplier of high-resolution molecular imaging systems, announced today that it has received ISO 13485 certification. The certification confirms Dilon's commitment to continual improvement of products, customer satisfaction, compliance with statutory and regulatory requirements and risk management.

ISO 13485 is an internationally recognized standard system which defines the requirements for design, development, production, and distribution of medical devices. It ensures conformity with specified quality controls in the development of safe and effective medical devices.

The Dilon 6800 Gamma Camera, Dilon's cornerstone product, is a high-resolution, small field-of-view gamma camera optimized to perform Breast-Specific Gamma Imaging (BSGI). BSGI is a molecular breast imaging procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. The Dilon 6800 captures vital information by viewing the metabolic activity in the breast; it can identify lesions independent of tissue density and is capable of duplicating standard mammographic views. In addition the Dilon GammaLoc™ system, an accessory to the Dilon 6800®, is the only FDA-cleared localization device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with BSGI.

Dilon's recent distribution agreement with Philips, allows the renowned healthcare company to sell and support the Dilon products in European and key Middle Eastern markets. The partnership with the global leader in medical technology demonstrates the significant endorsement of MBI/BSGI and its continued commitment to deliver the most advanced women's health solutions worldwide.

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

SOURCE Dilon Diagnostics

Back to top

RELATED LINKS
http://www.dilon.com

'/>"/>

SOURCE Dilon Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
2. Quest Diagnostics Unveils Care360(TM) EHR
3. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
4. Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
5. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
6. Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.
7. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
8. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
9. Fujirebio Diagnostics Named Life Sciences Company of the Year
10. U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology
11. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus host ... 2016-2021 and CAGR of 3% from 2021-2027. The market is expected to ... is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in ... How this report will ... future business opportunities emerging in this sector. In this brand ...
(Date:2/19/2017)...  nThrive™, an independent Patient-to-Payment? solutions company will ... at the 2017 HIMSS Conference. The company will ... KLAS. nThrive will host a Lunch ... trends shape the holistic, integrated revenue cycle of ... Access solution. The panel will reveal how health ...
(Date:2/19/2017)... and ORLANDO, Fla. , Feb. ... NKTR ) today announced that positive Phase 1 clinical ... with renal cell carcinoma (RCC) were presented at ASCO ... to expand specific cancer-fighting T cells and Natural Killer ... increase expression of PD-1 on these immune cells.  The ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... ... as an employee health benefit for companies that want to help members of ... providers, employees will have access to Watson’s suite of oncology offerings for insights ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... result in better care, and MEDfx and the Delaware Health Information Network (DHIN) ... , As the nation’s first state-wide health information exchange, DHIN stores and shares ...
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/17/2017)... ... February 17, 2017 , ... While ... Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue while ... Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the ...
Breaking Medicine News(10 mins):